Disc Medicine
Stock Forecast, Prediction & Price Target
Disc Medicine (IRON) stock Price Target by analysts
$90.33
Potential upside: 55.26%
Disc Medicine price prediction
What is Disc Medicine stock analysts` prediction?
Disc Medicine stock forecast: Based on 3 Wall Street analysts` predicted price targets for Disc Medicine in the last 3 months, the avarage price target is $90.33, with a high forecast of $NaN. The average price target represents a 55.26% change from the last price of $58.18.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Disc Medicine stock Price Target by analysts
Full breakdown of analysts given Disc Medicine price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Greg Harrison Scotiabank | 0% 0/1 | 11 months ago | $70 20.31% upside | $64.78 | StreetInsider | Previous targets (0) |
Evan David Seigerman BMO Capital | 0% 0/3 | 11 months ago | $112 92.50% upside | $63.24 | StreetInsider | Previous targets (2) |
Roger Song Jefferies | 0% 0/1 | 11 months ago | $89 52.97% upside | $50.92 | StreetInsider | Previous targets (0) |
Douglas Tsao H.C. Wainwright | 0% 0/1 | about 1 year ago | $70 20.31% upside | $47.79 | StreetInsider | Previous targets (0) |
Tiago Fauth Wells Fargo | 0% 0/1 | about 1 year ago | $75 28.91% upside | $49.31 | TheFly | Previous targets (0) |
Danielle Brill Raymond James | 0% 0/3 | about 1 year ago | $50 -14.05% downside | $42.85 | StreetInsider | Previous targets (2) |
Evan David Seigerman BMO Capital | 0% 0/3 | over 1 year ago | $70 20.31% upside | $45.8 | StreetInsider | Previous targets (2) |
Danielle Brill Raymond James | 0% 0/3 | over 1 year ago | $43 -26.09% downside | $29.95 | TheFly | Previous targets (2) |
Evan David Seigerman BMO Capital | 0% 0/3 | over 1 year ago | $50 -14.05% downside | $34.21 | StreetInsider | Previous targets (2) |
David Nierengarten Wedbush | 0% 0/1 | over 1 year ago | $43 -26.09% downside | $32 | StreetInsider | Previous targets (0) |
Ben Burnett Stifel Nicolaus | 0% 0/1 | over 1 year ago | $71 22.03% upside | $34.21 | StreetInsider | Previous targets (0) |
Danielle Brill Raymond James | 0% 0/3 | over 1 year ago | $40 -31.24% downside | $29.4 | TheFly | Previous targets (2) |
Disc Medicine Financial Estimates
Disc Medicine Revenue Estimates
Disc Medicine EBITDA Estimates
Disc Medicine Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $8.37M Low: $8.37M High: $8.37M avg. 0% | Avg: $3.34M Low: $3.34M High: $3.34M avg. -60.11% | Avg: $28.52M Low: $28.52M High: $28.52M avg. 754.05% | Avg: $145.73M Low: $145.73M High: $145.73M avg. 410.88% |
Net Income
% change YoY
| $-41.00M N/A | $-46.09M -12.40% | $-76.42M -65.82% | Avg: $-143.83M Low: $-120.72M High: $-101.53M avg. -88.19% | Avg: $-180.38M Low: $-154.64M High: $-112.24M avg. -25.40% | Avg: $-144.11M Low: $-144.11M High: $-144.11M avg. 20.10% | Avg: $-75.33M Low: $-75.33M High: $-75.33M avg. 47.72% |
EBITDA
% change YoY
| $-25.85M N/A | $-47.47M -83.64% | $-91.02M -91.73% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$12.8 N/A | -$44.34 -246.40% | -$3.43 92.26% | Avg: -$5.11 Low: -$5.41 High: -$4.55 avg. -49.02% | Avg: -$6.07 Low: -$6.93 High: -$5.03 avg. -18.82% | Avg: -$6.46 Low: -$6.46 High: -$6.46 avg. -6.32% | Avg: -$3.38 Low: -$3.38 High: -$3.38 avg. 47.72% |
Operating Expenses
% change YoY
| $30.93M N/A | $47.47M 53.47% | $91.12M 91.94% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Disc Medicine stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -11.44% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -120.72M, average is -143.83M and high is -101.53M.
What is Disc Medicine stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 276.20% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $8.37M, average is $8.37M and high is $8.37M.
What is Disc Medicine stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -6.61% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$5.41, average is -$5.11 and high is $-4.55.
What is the best performing analyst?
In the last twelve months 3 analysts have been covering Disc Medicine stock. The most successful analyst is Greg Harrison.